• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $ETHZ

    ETHZilla Corporation

    Subscribe to $ETHZ
    $ETHZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    IPO Year: 2017

    Exchange: NASDAQ

    Recent Analyst Ratings for ETHZilla Corporation

    DatePrice TargetRatingAnalyst
    See more ratings

    ETHZilla Corporation Press Releases

    Fastest customizable press release news feed in the world

    View All

    ETHZilla announces authorization of $250 million stock repurchase program

    Company has accumulated 102,237 ETH at an average acquisition price of $3,948.72, which is now valued at approximately $489 million Announces implementation of proprietary Electric Asset Protocol to generate higher yields PALM BEACH, Fla., Aug. 25, 2025 /PRNewswire/ -- ETHZilla Corporation (NASDAQ:ETHZ), (the "Company" or "ETHZilla"), today announced that its Board of Directors has authorized a stock repurchase program of up to $250 million of the Company's outstanding shares of common stock, effective immediately. Additionally, the Company announced it now has total holdings of 102,237 Ether ("ETH") at an average acquisition price of $3,948.72, which is now valued at approximately $489 mill

    8/25/25 8:00:00 AM ET
    $ETHZ
    Biotechnology: Pharmaceutical Preparations
    Health Care